Patient and sample characteristics
ID . | Sex . | Age, y . | IgVH . | ZAP-70 . | Genetic aberration . | Rai stage . | Previous therapy . |
---|---|---|---|---|---|---|---|
3 | Male | 57 | UM | Positive | Del 13q14 | 2 | Clb, ClbP |
9 | Male | 61 | UM | Positive | None | 2 | Clb, ClbP, R |
14 | Male | 71 | M | Negative | Del 13q14 homozygotic | 0 | None |
23 | Male | 67 | UM | ND | Del 13q14, Del 17p13 | 2 | None |
28 | Female | 66 | UM | Positive | None | 1 | Clb |
37 | Male | 65 | M | Negative | Del 13q14, trisomy 12 | 3 | Clb, ClbP, B |
39 | Male | 64 | M | ND | Del 13q14 | 2 | None |
43 | Male | 57 | M/UM | Negative | Trisomy12 | 2 | None |
45 | Male | 59 | M | Negative | Del 13q14 | 2 | None |
52 | Male | 74 | M | Negative | Del 13q14 | 2 | None |
54 | Male | 46 | UM | Positive | Del 18p11, trisomy 2p11 | 2 | F |
58 | Male | 72 | M | ND | Del 13q14, Del 5q15 | 2 | None |
59 | Male | 56 | UM | Positive | Del 17p13 | 4 | None |
61 | Male | 70 | M | ND | None | 2 | Clb |
85 | Male | 73 | M | Negative | Del 13q14 | 2 | None |
90 | Male | 74 | UM | ND | Del 13q14 | 3 | Clb |
95 | Male | 69 | M | Positive | Del 13q14 | 2 | Clb |
100 | Female | 76 | M | Negative | Del 13q14 | 2 | Clb, F |
101 | Male | 67 | M | Negative | Del 13q14 | 4 | Clb, ClbP |
107 | Female | 74 | M | Negative | Del 13q14 | 2 | Clb |
140 | Male | 55 | M | ND | Del 13q14 | 2 | None |
146 | Male | 69 | M | Negative | Del 13q14 | 0 | None |
159 | Male | 68 | M | Negative | Del 11q22 | 2 | Clb, R |
161 | Male | 71 | M | ND | Del 13q14 homozygotic | 0 | None |
163 | Male | 76 | M | ND | None | 0 | None |
186 | Male | 50 | M | ND | None | 1 | Clb |
202 | Male | 69 | M | Negative | Del 13q14 | 4 | F |
209 | Male | 68 | UM | ND | Del 2q13, trisomy 12 | 1 | Clb |
210 | Female | 68 | M | Negative | ND | 1 | None |
225 | Female | 58 | M | ND | Del13q14 | 3 | Clb, F |
300 | Male | 79 | ND | Negative | ND | 2 | None |
301 | Male | 75 | UM | ND | None | 4 | Clb, F |
ID . | Sex . | Age, y . | IgVH . | ZAP-70 . | Genetic aberration . | Rai stage . | Previous therapy . |
---|---|---|---|---|---|---|---|
3 | Male | 57 | UM | Positive | Del 13q14 | 2 | Clb, ClbP |
9 | Male | 61 | UM | Positive | None | 2 | Clb, ClbP, R |
14 | Male | 71 | M | Negative | Del 13q14 homozygotic | 0 | None |
23 | Male | 67 | UM | ND | Del 13q14, Del 17p13 | 2 | None |
28 | Female | 66 | UM | Positive | None | 1 | Clb |
37 | Male | 65 | M | Negative | Del 13q14, trisomy 12 | 3 | Clb, ClbP, B |
39 | Male | 64 | M | ND | Del 13q14 | 2 | None |
43 | Male | 57 | M/UM | Negative | Trisomy12 | 2 | None |
45 | Male | 59 | M | Negative | Del 13q14 | 2 | None |
52 | Male | 74 | M | Negative | Del 13q14 | 2 | None |
54 | Male | 46 | UM | Positive | Del 18p11, trisomy 2p11 | 2 | F |
58 | Male | 72 | M | ND | Del 13q14, Del 5q15 | 2 | None |
59 | Male | 56 | UM | Positive | Del 17p13 | 4 | None |
61 | Male | 70 | M | ND | None | 2 | Clb |
85 | Male | 73 | M | Negative | Del 13q14 | 2 | None |
90 | Male | 74 | UM | ND | Del 13q14 | 3 | Clb |
95 | Male | 69 | M | Positive | Del 13q14 | 2 | Clb |
100 | Female | 76 | M | Negative | Del 13q14 | 2 | Clb, F |
101 | Male | 67 | M | Negative | Del 13q14 | 4 | Clb, ClbP |
107 | Female | 74 | M | Negative | Del 13q14 | 2 | Clb |
140 | Male | 55 | M | ND | Del 13q14 | 2 | None |
146 | Male | 69 | M | Negative | Del 13q14 | 0 | None |
159 | Male | 68 | M | Negative | Del 11q22 | 2 | Clb, R |
161 | Male | 71 | M | ND | Del 13q14 homozygotic | 0 | None |
163 | Male | 76 | M | ND | None | 0 | None |
186 | Male | 50 | M | ND | None | 1 | Clb |
202 | Male | 69 | M | Negative | Del 13q14 | 4 | F |
209 | Male | 68 | UM | ND | Del 2q13, trisomy 12 | 1 | Clb |
210 | Female | 68 | M | Negative | ND | 1 | None |
225 | Female | 58 | M | ND | Del13q14 | 3 | Clb, F |
300 | Male | 79 | ND | Negative | ND | 2 | None |
301 | Male | 75 | UM | ND | None | 4 | Clb, F |
UM indicates unmutated; M, mutated, ND, not done; Clb, chlorambucil; ClbP, chlorambucil + prednisone; F, fludarabine; B, bendamustin; and R, rituximab.